✦ LIBER ✦

Long-term management issues in restless legs syndrome

✍ Scribed by Sudhansu Chokroverty

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 122 KB
Volume: 26
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.23652

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Restless legs syndrome is a neurologic movement and sleep disorder with lifelong symptoms causing considerable morbidity. Several short‐term and some long‐term open‐label and double‐blind clinical trials have demonstrated the efficacy and safety of dopaminergic treatment in restless legs syndrome. Long‐term treatment, however, is associated with the emergence of vexing long‐term side effects that pose a challenge for physicians. These long‐term complications can be broadly categorized as disease‐related (impact on sleep and acute exacerbation of restless legs syndrome symptoms), and medication issues (augmentation, sleep attacks, impulse control disorders, addiction and dependence, site reaction, occasionally sleep apnea, fibrotic complications, and weight gain). © 2011 Movement Disorder Society

📜 SIMILAR VOLUMES

Augmentation of restless legs syndrome w

Augmentation of restless legs syndrome with long-term tramadol treatment

✍ Roberto Vetrugno; Chiara La Morgia; Roberto D'Angelo; Daniela Loi; Federica Prov 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

## Abstract Restless legs syndrome (RLS) augmentation, defined as a kind of suppression of the circadian rhythm of the disease in which sensory and motor symptoms appear earlier during the day (and over previously unaffected body parts), with a progressive phase advance until, backwards, the sympto

Ropinirole is effective in the long-term

Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial

✍ Jacques Montplaisir; Jeff Karrasch; Jean Haan; Dieter Volc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 1 views

## Abstract The objective of this study was to investigate the long‐term efficacy of ropinirole in patients with restless legs syndrome (RLS) and to assess the potential for relapse after the discontinuation of active treatment. Patients with primary RLS (n = 202) received single‐blind ropinirole f

Long-term course of restless legs syndro

Long-term course of restless legs syndrome in dialysis patients after kidney transplantation

✍ Juliane Winkelmann; Anette Stautner; Walter Samtleben; Claudia Trenkwalder 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

## Abstract Restless legs syndrome (RLS) is a common cause of sleep disturbance and is frequently experienced by hemodialysis patients. Factors triggering the disease in uremia have not yet been identified. To our knowledge, the course of RLS symptoms after kidney transplantation has not been inves

Long-Term follow-up on restless legs syn

Long-Term follow-up on restless legs syndrome patients treated with opioids

✍ Arthur S. Walters; Juliane Winkelmann; Claudia Trenkwalder; June M. Fry; Vandana 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

## Abstract The medical records of 493 patients with restless legs syndrome (RLS) from three major centers were studied to determine the number and outcome of patients who had been treated with opioids as a monotherapy. At one time or another 113 patients (51 men, 62 women; age range, 37–88 years)

Restless legs in Tourette syndrome

✍ P. Lespérance; N. Djerroud; A. Diaz Anzaldua; G.A. Rouleau; S. Chouinard; F. Ric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

## Abstract Restless legs syndrome (RLS) and Tourette's syndrome (TS) share some common features, including the phenomenology of sensations relieved by movements, but few studies have examined the links between RLS and TS. We examined RLS and other TS comorbidities in 144 probands with TS or chroni

CAG repeats in restless legs syndrome

✍ Markus Konieczny; Peter Bauer; Jürgen Tomiuk; Gabriele Weisser; Jean Haan; Klaus 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views